Indications
Treatment of adults, adolescents and children aged 10 years and above with insufficiently controlled type 2 diabetes as an adjunct to diet and exercise
Composition
- Active substance
- liraglutide
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Liraglutide STADA
- Active substance
- liraglutide
- ATC code
- A10BJ02
- Therapeutic area
- Diabetes Mellitus
- Marketing authorisation holder
- STADA Arzneimittel AG
- Status
- CHMP opinion
- EMA product number